🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
ZM-H1505R is an investigational drug developed by Shanghai Zhimeng Biopharm...
Status
Completed
Location
Frontage Clinical Services
Start Date
2020-02-17
Trial ID
NCT04220801
Treatments Being Tested
A Phase 1, First-In-Human, Randomized, Double-Blind, Placebo-Controlled Mul...
Status
Completed
Location
Nucleus Network Pty Ltd
Start Date
2025-05-29
Trial ID
NCT06981299
Treatments Being Tested
This multi-center, randomized, double blind, parallel-group, placebo-contro...
Status
Completed
Location
Multiple Locations
Start Date
2010-12
Trial ID
NCT01192906
Treatments Being Tested
The purpose of this study is to investigate the safety and activity in the ...
Status
Completed
Location
Arensia Clinical Research Unit
Start Date
2019-08-14
Trial ID
NCT04073498
The purpose of this study is to evaluate the safety, tolerability, single-a...
Status
Completed
Location
Parexel International
Start Date
2024-07-11
Trial ID
NCT06562114
Treatments Being Tested
The Phase 1 study described herein will evaluate the safety, tolerability, ...
Status
Recruiting
Location
Xencor Investigative Site
Start Date
2024-10-10
Trial ID
NCT06619990
The purpose of this study is to evaluate the safety and the efficacy of Gly...
Status
Completed
Location
Medicines Evaluation Unit
Start Date
2010-08
Trial ID
NCT01176903
Treatments Being Tested
The objective of this phase III, placebo-controlled platform study is to in...
Status
Terminated
Location
Flinders Medical Centre
Start Date
2021-08-09
Trial ID
NCT06008249
Treatments Being Tested
This study adopted a single-center, randomized, double-blind, placebo-contr...
Status
Completed
Location
Beijing Anzhen Hospital, Capital Medical University
Start Date
2025-08-06
Trial ID
NCT07083362
Treatments Being Tested
TLL018 is developed for treatment of autoimmune and inflammatory diseases i...
Status
Completed
Location
Frontage Clinical Services, Inc.
Start Date
2020-01-26
Trial ID
NCT04243083
Treatments Being Tested